Compare RANI & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | BIOX |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.6M | 109.2M |
| IPO Year | 2021 | N/A |
| Metric | RANI | BIOX |
|---|---|---|
| Price | $1.48 | $1.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.67 | $4.42 |
| AVG Volume (30 Days) | ★ 2.8M | 375.5K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,200,000.00 | ★ $318,158,904.00 |
| Revenue This Year | $414.59 | $1.25 |
| Revenue Next Year | $30.15 | $27.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.39 | $1.20 |
| 52 Week High | $3.87 | $7.44 |
| Indicator | RANI | BIOX |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 47.43 |
| Support Level | $1.52 | $1.40 |
| Resistance Level | $1.67 | $1.78 |
| Average True Range (ATR) | 0.14 | 0.12 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 28.57 | 48.67 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.